Hanlin Gao's most recent trade in Fulgent Genetics Inc was a trade of 754 Common Stock done at an average price of $20.3 . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.29 per share. | 02 Jun 2025 | 754 | 961,281 (5%) | 0% | 20.3 | 15,299 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.52 per share. | 27 May 2025 | 656 | 962,035 (5%) | 0% | 20.5 | 13,459 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.57 per share. | 27 May 2025 | 383 | 962,691 (5%) | 0% | 20.6 | 7,880 | Common Stock |
| Fulgent Genetics Inc | Gao Hanlin | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.35 per share. | 30 Apr 2025 | 79 | 963,074 (5%) | 0% | 17.4 | 1,371 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. | 26 Apr 2025 | 1,157 | 963,153 (5%) | 0% | 18.9 | 21,844 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.45 per share. | 01 Mar 2025 | 985 | 964,310 (5%) | 0% | 15.4 | 15,218 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 37,790 | 967,818 (5%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 11,926 | 937,514 (5%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.29 per share. | 25 Feb 2025 | 4,639 | 930,028 (4%) | 0% | 16.3 | 75,569 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 4,571 | 925,588 (4%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 3,384 | 921,017 (4%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.24 per share. | 25 Feb 2025 | 2,523 | 965,295 (5%) | 0% | 16.2 | 40,974 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.29 per share. | 25 Feb 2025 | 1,636 | 934,667 (4%) | 0% | 16.3 | 26,650 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.29 per share. | 25 Feb 2025 | 1,211 | 936,303 (5%) | 0% | 16.3 | 19,727 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.46 per share. | 23 Feb 2025 | 417 | 917,633 (4%) | 0% | 16.5 | 6,864 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.00 per share. | 30 Jan 2025 | 90 | 918,050 (4%) | 0% | 17 | 1,530 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.21 per share. | 26 Jan 2025 | 1,329 | 918,140 (4%) | 0% | 17.2 | 22,872 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 03 Dec 2024 | 1,373 | 919,469 (4%) | 0% | 19.5 | 26,773 | Common Stock |
| Fulgent Genetics Inc | Gao Hanlin | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.26 per share. | 25 Nov 2024 | 497 | 920,842 (4%) | 0% | 18.3 | 9,075 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.27 per share. | 30 Oct 2024 | 79 | 921,339 (4%) | 0% | 20.3 | 1,601 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.42 per share. | 26 Oct 2024 | 1,639 | 921,418 (4%) | 0% | 19.4 | 31,829 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 21.96 per share. | 03 Sep 2024 | 1,503 | 923,057 (4%) | 0% | 22.0 | 33,007 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 22.83 per share. | 27 Aug 2024 | 563 | 924,560 (4%) | 0% | 22.8 | 12,855 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.95 per share. | 30 Jul 2024 | 111 | 925,123 (4%) | 0% | 23.9 | 2,658 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.66 per share. | 26 Jul 2024 | 1,154 | 925,234 (4%) | 0% | 23.7 | 27,304 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.65 per share. | 01 Jun 2024 | 714 | 926,656 (4%) | 0% | 20.6 | 14,744 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.65 per share. | 01 Jun 2024 | 268 | 926,388 (4%) | 0% | 20.6 | 5,534 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.14 per share. | 23 May 2024 | 362 | 927,370 (4%) | 0% | 21.1 | 7,653 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.35 per share. | 30 Apr 2024 | 79 | 927,732 (4%) | 0% | 20.4 | 1,608 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.10 per share. | 26 Apr 2024 | 1,154 | 927,811 (4%) | 0% | 20.1 | 23,195 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.24 per share. | 01 Mar 2024 | 704 | 929,233 (4%) | 0% | 23.2 | 16,361 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.24 per share. | 01 Mar 2024 | 268 | 928,965 (4%) | 0% | 23.2 | 6,228 | Common Stock |
| Fulgent Genetics Inc | Gao Hanlin | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 21,146 | 929,937 (4%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 5,304 | 912,081 (4%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Gao Hanlin | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 3,927 | 906,777 (4%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.26 per share. | 26 Feb 2024 | 1,888 | 908,791 (4%) | 0% | 24.3 | 45,803 | Common Stock |
| Fulgent Genetics Inc | Gao Hanlin | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.26 per share. | 26 Feb 2024 | 1,402 | 910,679 (4%) | 0% | 24.3 | 34,013 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.06 per share. | 23 Feb 2024 | 1,617 | 902,850 (4%) | 0% | 24.1 | 38,905 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.00 per share. | 30 Jan 2024 | 90 | 904,467 (4%) | 0% | 25 | 2,250 | Common Stock |
| Fulgent Genetics Inc | Gao Hanlin | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.60 per share. | 26 Jan 2024 | 1,325 | 904,557 (4%) | 0% | 25.6 | 33,920 | Common Stock |